FDA grants Centinel Spine allogeneic bone graft indications for lumbar spinal fusion line — 5 key notes

By Laura Dyrda

Centinel Spine received an allogeneic bone graft indication for its anterior lumbar product family.

Here are five things to know:

Advertisement

1. The FDA cleared the STALIF MIDLINE, MIDLINE II and MIDLINE II-Ti (Ti-ACTIVE) devices for use with allogeneic bone graft in lumbar spinal fusions.

2. The Centinel Spine standalone devices have a no-profile design and are integrated interbody systems for use with autograft and/or allogeneic bone graft in lumbar and cervical fusion procedures.

READ MORE HERE

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement